ViviCells International Inc (VCII)

[locksflooring]

Cord has a non-controlling equity investment in ViviCells International, Inc., a privately held company in the business of providing blood stem cell and adult peripheral blood stem cell preservation services. The Company utilizes the equity method of accounting as it owns more than 20% of the outstanding common stock and has the ability to exercise significant influence over this company. As such, the investment is carried at cost less Cord’s proportionate share of ViviCells net loss for the period since investment. At March 31, 2011, the carrying amount of this investment is $0.